 |
市場調查報告書
商品編碼
1391930
狂犬病血清市場：依類型、依應用、依配銷通路、依地區Rabies Antiserum Market, By Type (Monoclonal Antibodies, Polyclonal Antibodies), By Application (Pre-Exposure Prophylaxis, Post-Exposure Prophylaxis ), By Distribution Channel, By Geography |
||||||
2023年全球狂犬病血清市場規模將達12.4億美元。預計2023年至2030年該市場將以3.3%的複合年成長率成長，到年終市場規模將達到15.6億美元。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2022年 | 2023年市場規模 | 12.4億美元 |
| 實績資料 | 2018-2021 | 預測期 | 2023-2030 |
| 預測期複合年成長率 | 3.30% | 2030年市場規模預測 | 15.6億美元 |
狂犬病血清用於保護接觸可能患有狂犬病的動物的人。狂犬病是一種嚴重且幾乎總是致命的疾病，透過被感染動物的唾液咬傷和抓傷傳播給人類和其他動物。狂犬病是一種嚴重的疾病，可以透過被咬傷或抓傷（吐口水）的受感染動物的唾液傳播給人類和其他動物。建議前往高風險地區的旅客接種一系列暴露前狂犬病疫苗和暴露後預防 (PEP)，以防被感染動物咬傷或抓傷。狂犬病免疫球蛋白有兩種：人類狂犬病免疫球蛋白（HRIG）和馬狂犬病免疫球蛋白（ERIG）。如果有的話，HRIG 是首選，但如果沒有，ERIG 可以有效中和狂犬病病毒。
市場動態：
狂犬病預防的需求和狗咬傷發生率的上升預計將支持狂犬病血清市場的成長。此外，狂犬病疫苗接種意識的提高預計也將推動市場成長。此外，技術進步和消費行為的變化也是預測期內推動市場成長的主要因素。
另一方面，缺乏對先進技術的認知預計將限制市場成長。政府公共衛生機構和國際組織的認知配合措施有限也限制了市場的成長。據世界衛生組織稱，2021 年，超過 109 個國家報告了人類和動物狂犬病病例。然而，國家監測系統薄弱，許多貧窮國家無法可靠地記錄真實的發病率。由於準確的流行病學資料尚未公開，狂犬病造成的真正威脅往往被低估。這對調動政策關注和擴大狂犬病預防計畫所需的資源（包括抗血清等生技藥品的供應）構成了重大障礙。
本研究的主要特點
- 本報告詳細分析了全球狂犬病血清市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
- 它還揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
- 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
- 該報告根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球狂犬病血清市場的主要企業。
- 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出資訊的決策。
- 全球狂犬病血清市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
- 透過用於分析全球狂犬病血清市場的各種策略矩陣，將促進相關人員的決策。
目錄
第1章 研究目的與假設
- 研究目標
- 假設
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規及趨勢分析
- 市場動態
- 促進因素
- 狗咬傷事件增加
- 提高狂犬病疫苗接種意識
- 抑制因素
- 缺乏先進技術意識
- 機會
- 政府支持配合措施
- 影響分析
- 主要亮點
- 監管場景
- 產品發布/核准
- PEST分析
- 波特的分析
- 併購場景
第4章狂犬病血清市場－冠狀病毒（COVID-19）大流行的影響
- 新型冠狀病毒感染疾病（COVID-19）的流行病學
- 供需面分析
- 經濟影響
第5章狂犬病血清市場，依類型，2018-2030
- 介紹
- 單株抗體（mAb）
- 多克隆抗體
第6章狂犬病血清市場，依應用分類，2018-2030
- 介紹
- 暴露前預防 (PrEP)
- 暴露後預防 (PEP)
第7章狂犬病血清市場，依配銷通路，2018-2030
- 介紹
- 醫院藥房
- 零售藥房
- 線上藥房
第8章狂犬病血清市場，依地區，2018-2030
- 介紹
- 北美洲
- 美國
- 加拿大
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 歐洲其他地區
- 亞太地區
- 中國
- 印度
- 日本
- 東南亞國協
- 澳洲
- 韓國
- 其他亞太地區
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中部非洲
- 南非
第9章競爭形勢
- CSL Behring
- Sanofi Pasteur
- Grifols SA
- Bharat Serum and Vaccines Ltd.
- Novartis AG
- Kedrion Biopharma Inc.
- Biogenesis Bago SA
- Serum Institute of India Ltd.
- Haffkine Bio-Pharmaceutical Corporation Ltd.
- Shanghai Institute of Biological Products Co. Ltd.
- CNBG（China National Biotec Group）Co. Ltd.
- Harbin Pharmaceutical Group Co. Ltd.
- Beijing Tiantan Biological Products Co. Ltd.
第10章
- 調查方法
- 關於出版商
The global rabies antiserum market size was valued at USD 1.24 billion in 2023. The market is projected to grow at a CAGR of 3.3% from 2023 to 2030, resulting in an estimated market size of USD 1.56 billion by the end of 2030.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 1.24 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 3.30% | 2030 Value Projection: | US$ 1.56 Bn |
Rabies antiserum is used to protect people who have been exposed to a potentially rabid animal. Rabies is a serious, almost always fatal disease that spreads from the saliva (spit) of an infected animal through a bite or scratch to humans and other animals. It can be prevented by getting immediate medical care and immunizations after the exposure. It is recommended that travelers to high-risk areas have a pre-exposure rabies vaccine series and be prepared with post-exposure prophylaxis (PEP) in case they are bitten or scratched by an infected animal. There are two types of rabies immunoglobulin available: human rabies immunoglobulin (HRIG) and equine rabies immunoglobulin (ERIG). HRIG is preferable when it is available, but if it is not, ERIG will be effective in neutralizing the rabies virus.
Market Dynamics:
The need to prevent rabies and the rising incidence of dog bites are expected to support growth of the rabies antiserum market. Additionally, the growing awareness regarding rabies vaccinations is also expected to propel growth of the market. Moreover, technological advancements and changing consumer behavior are other major factors expected to drive growth of the market over the forecast period.
On the other hand, a lack of awareness regarding advanced technology is expected to restrict market growth. Limited efforts by government public health agencies and international organizations towards awareness-generation activities have also restricted market growth. According to the WHO, in 2021, over 109 countries reported rabies cases in both humans and animals. But national surveillance systems were weak to reliably record the true incidence in many poorer nations. Without accurate epidemiological data available in the public domain, the real threat posed by rabies tends to get underestimated. This acts as a major roadblock in mobilizing necessary policy attention and resources for expanding rabies prevention programs, including the supply of biologics like antiserum.
Key features of the study:
- This report provides in-depth analysis of the global rabies antiserum market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global rabies antiserum market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include CSL Behring, Sanofi Pasteur, Grifols S.A., Bharat Serum and Vaccines Ltd., Novartis AG, Kedrion Biopharma Inc., Biogenesis Bago SA, MassBiologics, Serum Institute of India Ltd., Green Cross Corp., Haffkine, Bio-Pharmaceutical Corporation Ltd., Shanghai Institute of Biological Products Co. Ltd., CNBG (China National Biotec Group) Co. Ltd., Harbin Pharmaceutical Group Co. Ltd., and Beijing Tiantan Biological Products Co. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global rabies antiserum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rabies antiserum market
Detailed Segmentation:
- Rabies Antiserum Market, By Type
- Monoclonal Antibodies (mAbs)
- Polyclonal Antibodies
- Rabies Antiserum Market, By Application
- Pre-Exposure Prophylaxis (PrEP)
- Post-Exposure Prophylaxis (PEP)
- Rabies Antiserum Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Rabies Antiserum Market, By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Key Players
- CSL Behring
- Sanofi Pasteur
- Grifols S.A.
- Bharat Serum and Vaccines Ltd.
- Novartis AG
- Kedrion Biopharma Inc.
- Biogenesis Bago SA
- Serum Institute of India Ltd.
- Haffkine Bio-Pharmaceutical Corporation Ltd.
- Shanghai Institute of Biological Products Co. Ltd.
- CNBG (China National Biotec Group) Co. Ltd.
- Harbin Pharmaceutical Group Co. Ltd.
- Beijing Tiantan Biological Products Co. Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Rabies Antiserum, By Type
- Market Rabies Antiserum, By Application
- Market Rabies Antiserum, By Distribution Channel
- Market Rabies Antiserum, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rising incidence of dog bites
- Growing awareness regarding rabies vaccinations
- Restraints
- Lack of awareness regarding advanced technologies
- Opportunities
- Supportive government initiatives
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Rabies Antiserum Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Rabies Antiserum Market , By Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Monoclonal Antibodies (mAbs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
- Polyclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2030, (US$ Bn)
6. Rabies Antiserum Market , By Application, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Pre-Exposure Prophylaxis (PrEP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
- Post-Exposure Prophylaxis (PEP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
7. Rabies Antiserum Market , By Distribution Channel, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
8. Rabies Antiserum Market , By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2023 -2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- CSL Behring
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi Pasteur
- Grifols S.A
- Bharat Serum and Vaccines Ltd.
- Novartis AG
- Kedrion Biopharma Inc.
- Biogenesis Bago SA
- Serum Institute of India Ltd.
- Haffkine Bio-Pharmaceutical Corporation Ltd.
- Shanghai Institute of Biological Products Co. Ltd.
- CNBG (China National Biotec Group) Co. Ltd.
- Harbin Pharmaceutical Group Co. Ltd.
- Beijing Tiantan Biological Products Co. Ltd.
- Analyst Views
10. Section
- Research Methodology
- About us
